ALLMedicine™ Prostate Cancer Center
Research & Reviews 85,983 results
https://doi.org/10.2967/jnumed.120.259630
Journal of Nuclear Medicine : Official Publication, Socie... Baratto L, Song H et. al.
Mar 6th, 2021 - Rationale: Novel radiopharmaceuticals for positron emission tomography (PET) are evaluated for the diagnosis of biochemically recurrent prostate cancer (BCR PC). Here, we compare the gastrin releasing peptide receptors (GRPR) - targeting 68Ga-RM2 ...
https://doi.org/10.1097/01.NURSE.0000734040.37831.77
Nursing
Mar 6th, 2021 - Online resources for patients with prostate cancer.|2021||
https://doi.org/10.1038/s41388-021-01724-6 10.1038/ncpuro1296 10.1038/modpathol.2017.158 10.1016/j.cell.2015.10.025 10.1101/gad.315739.118 10.1038/sj.onc.1204383 10.1038/ncb0502-e131 10.1038/nrc1209 10.1002/path.1605 10.1158/1078-0432.CCR-07-4120 10.1038/cdd.2014.213 10.1016/j.biopha.2019.109679 10.1073/pnas.1209660109 10.1074/jbc.M116.714899 10.1158/0008-5472.CAN-07-6055 10.1186/1471-2407-5-45 10.1016/j.molonc.2013.02.005 10.1016/j.cell.2014.09.014 10.1186/1471-2407-7-64 10.1038/sj.onc.1202195 10.1016/S1535-6108(03)00215-0 10.1158/0008-5472.CAN-09-2370 10.1038/mt.2008.76 10.1016/j.ejca.2005.08.008 10.1016/S1535-6108(03)00280-0 10.1046/j.0022-3042.2002.00807.x 10.1038/ncb2590 10.1101/gad.13.5.607 10.1073/pnas.0304146101 10.1186/s13059-016-1012-2
Oncogene Riedel M, Berthelsen MF et. al.
Mar 6th, 2021 - Prostate cancer is a major global health concern with limited treatment options for advanced disease. Its heterogeneity challenges the identification of crucial driver genes implicated in disease progression. Activating protein-1 (AP-1) transcript...
https://doi.org/10.1093/ajcn/nqaa414
The American Journal of Clinical Nutrition; Cai H, Scott EN et. al.
Mar 6th, 2021 - The dietary polyphenol resveratrol prevents various malignancies in preclinical models, including prostate cancer. Despite attempts to translate findings to humans, gaps remain in understanding pharmacokinetic-pharmacodynamic relations and how tis...
https://doi.org/10.1007/s00345-021-03649-x 10.1016/j.annonc.2020.06.011 10.1111/bju.14815 10.1111/iju.13593 10.1016/j.euf.2019.06.004 10.1126/scitranslmed.3003180 10.1038/s41598-019-53384-y 10.1016/j.eururo.2020.12.037 10.1111/iju.13734 10.1016/j.urolonc.2017.11.017 10.1172/jci.insight.122109 10.1172/JCI131041 10.1038/s41598-020-78766-5 10.1038/s41391-018-0043-z 10.1038/s41598-019-40719-y 10.1016/j.ejca.2019.05.007 10.1111/iju.13526 10.1200/JCO.2017.77.6880 10.1002/iju5.12172 10.1158/1078-0432.Ccr-08-1910 10.1200/jco.2007.12.4487 10.1111/iju.14258 10.1111/eci.13015 10.1007/s00414-018-1945-y 10.1007/978-1-4939-8973-7_1 10.1016/j.clgc.2017.12.008 10.1093/annonc/mdx155 10.1038/s41585-019-0237-8 10.1158/1078-0432.Ccr-20-3708 10.1016/j.eururo.2018.12.042 10.1016/j.eururo.2019.08.020
World Journal of Urology; Kubota Y, Hatakeyama S et. al.
Mar 6th, 2021 - To investigate the prognostic significance of total cell-free DNA (cfDNA) level and androgen receptor amplification (AR-amp) in patients with castration-resistant prostate cancer (CRPC). We retrospectively compared the total cfDNA level and AR-amp...
Guidelines 391 results
https://doi.org/10.1016/j.prro.2020.10.002
Practical Radiation Oncology; Zietman AL,
Dec 14th, 2020 - ASTRO Editorial: The AUA-ASTRO-SUO Advanced Prostate Cancer Guidelines: A Continued but Changing Role for the Radiation Oncologist.|2020|Zietman AL, ,|
https://doi.org/10.1097/JU.0000000000001376
The Journal of Urology; Lowrance WT, Breau RH et. al.
Sep 22nd, 2020 - The summary presented herein represents Part II of the two-part series dedicated to Advanced Prostate Cancer: AUA/ASTRO/SUO Guideline discussing prognostic and treatment recommendations for patients with castration-resistant disease. Please refer ...
https://doi.org/10.1097/JU.0000000000001375
The Journal of Urology; Lowrance WT, Breau RH et. al.
Sep 22nd, 2020 - The summary presented herein represents Part I of the two-part series dedicated to Advanced Prostate Cancer: AUA/ASTRO/SUO Guideline discussing prognostic and treatment recommendations for patients with biochemical recurrence without metastatic di...
https://doi.org/10.1016/j.prro.2020.06.009
Practical Radiation Oncology; Bauman GS, Jani AB
Sep 6th, 2020 - American Society for Radiation Oncology Editorial: Rapidly Evolving Technologies Related to Imaging Strategies for Advanced Prostate Cancer.|2020|Bauman GS,Jani AB,|
https://doi.org/10.1002/pros.24053
The Prostate REFERENCES; Shore ND, Drake CG et. al.
Aug 11th, 2020 - Advanced prostate cancer (PC) patients, especially those with metastatic prostate cancer (mPC), often require complex management pathways. Despite the publication of clinical practice guidelines by leading urological and oncological organizations ...
Drugs 339 results see all →
Clinicaltrials.gov 93,717 results
https://doi.org/10.2967/jnumed.120.259630
Journal of Nuclear Medicine : Official Publication, Socie... Baratto L, Song H et. al.
Mar 6th, 2021 - Rationale: Novel radiopharmaceuticals for positron emission tomography (PET) are evaluated for the diagnosis of biochemically recurrent prostate cancer (BCR PC). Here, we compare the gastrin releasing peptide receptors (GRPR) - targeting 68Ga-RM2 ...
https://doi.org/10.1097/01.NURSE.0000734040.37831.77
Nursing
Mar 6th, 2021 - Online resources for patients with prostate cancer.|2021||
https://doi.org/10.1038/s41388-021-01724-6 10.1038/ncpuro1296 10.1038/modpathol.2017.158 10.1016/j.cell.2015.10.025 10.1101/gad.315739.118 10.1038/sj.onc.1204383 10.1038/ncb0502-e131 10.1038/nrc1209 10.1002/path.1605 10.1158/1078-0432.CCR-07-4120 10.1038/cdd.2014.213 10.1016/j.biopha.2019.109679 10.1073/pnas.1209660109 10.1074/jbc.M116.714899 10.1158/0008-5472.CAN-07-6055 10.1186/1471-2407-5-45 10.1016/j.molonc.2013.02.005 10.1016/j.cell.2014.09.014 10.1186/1471-2407-7-64 10.1038/sj.onc.1202195 10.1016/S1535-6108(03)00215-0 10.1158/0008-5472.CAN-09-2370 10.1038/mt.2008.76 10.1016/j.ejca.2005.08.008 10.1016/S1535-6108(03)00280-0 10.1046/j.0022-3042.2002.00807.x 10.1038/ncb2590 10.1101/gad.13.5.607 10.1073/pnas.0304146101 10.1186/s13059-016-1012-2
Oncogene Riedel M, Berthelsen MF et. al.
Mar 6th, 2021 - Prostate cancer is a major global health concern with limited treatment options for advanced disease. Its heterogeneity challenges the identification of crucial driver genes implicated in disease progression. Activating protein-1 (AP-1) transcript...
https://doi.org/10.1093/ajcn/nqaa414
The American Journal of Clinical Nutrition; Cai H, Scott EN et. al.
Mar 6th, 2021 - The dietary polyphenol resveratrol prevents various malignancies in preclinical models, including prostate cancer. Despite attempts to translate findings to humans, gaps remain in understanding pharmacokinetic-pharmacodynamic relations and how tis...
https://doi.org/10.1007/s00345-021-03649-x 10.1016/j.annonc.2020.06.011 10.1111/bju.14815 10.1111/iju.13593 10.1016/j.euf.2019.06.004 10.1126/scitranslmed.3003180 10.1038/s41598-019-53384-y 10.1016/j.eururo.2020.12.037 10.1111/iju.13734 10.1016/j.urolonc.2017.11.017 10.1172/jci.insight.122109 10.1172/JCI131041 10.1038/s41598-020-78766-5 10.1038/s41391-018-0043-z 10.1038/s41598-019-40719-y 10.1016/j.ejca.2019.05.007 10.1111/iju.13526 10.1200/JCO.2017.77.6880 10.1002/iju5.12172 10.1158/1078-0432.Ccr-08-1910 10.1200/jco.2007.12.4487 10.1111/iju.14258 10.1111/eci.13015 10.1007/s00414-018-1945-y 10.1007/978-1-4939-8973-7_1 10.1016/j.clgc.2017.12.008 10.1093/annonc/mdx155 10.1038/s41585-019-0237-8 10.1158/1078-0432.Ccr-20-3708 10.1016/j.eururo.2018.12.042 10.1016/j.eururo.2019.08.020
World Journal of Urology; Kubota Y, Hatakeyama S et. al.
Mar 6th, 2021 - To investigate the prognostic significance of total cell-free DNA (cfDNA) level and androgen receptor amplification (AR-amp) in patients with castration-resistant prostate cancer (CRPC). We retrospectively compared the total cfDNA level and AR-amp...
News 6,535 results
https://www.medscape.com/viewarticle/946349
Feb 24th, 2021 - NEW YORK (Reuters Health) - Photoselective vaporization of the prostate can provide relief from refractory lower-urinary-tract symptoms (LUTS) resulting from benign prostatic hyperplasia (BPH) in prostate cancer patients managed by active surveill...
https://www.medscape.com/viewarticle/946211
Feb 23rd, 2021 - NEW YORK (Reuters Health) - Dose-intensified salvage radiotherapy is not superior to conventional dose salvage RT and is associated with increased late rectal toxicity in patients with biochemical recurrence of prostate cancer after prostatectomy,...
https://www.medscape.com/viewarticle/945928
Feb 22nd, 2021 - Patients with prostate cancer have a right to expect that their screening, diagnosis, and treatment are supported by evidence-based science. But how well does the urology community measure up when it comes to claims that standard-of-care practices...
https://www.medscape.com/viewarticle/946187
Feb 21st, 2021 - Could imaging be used for routine screening for prostate cancer in healthy men — similar to mammography for breast cancer screening? A quick scan — with 15-minute, contrast-free MRI — detected more clinically significant prostate tumors than the u...
https://www.medscape.com/viewarticle/946111
Feb 18th, 2021 - The results of a trial led by Medical Detection Dogs in Milton Keynes suggest that trained dogs can detect advanced prostate cancer in urine samples with high specificity and sensitivity. The study, published in PLoS One, tested the clinical fea...
